Ahead of PharmSci 360, DigiM CEO on turning hidden microstructures into drug-release predictions

ConferenceNeutral

AI Analysis

Summary

DigiM CEO to speak at PharmSci 360 conference about using microstructure analysis to predict drug-release profiles and improve formulation development timelines. Article focuses on formulation science challenges and drug dissolution measurement.

Importance:2/10

Sentiment:

0.00

formulation developmentdrug dissolutionmicrostructure analysisPharmSci 360 conference

Related Companies

$TPTX $TRAX

Read the original article

Published by Drug Discovery & Development on July 29, 2026 4:17 PM

Read Original